Apex gets approval for ‘world’s largest’ take home psychedelic trial
The company plans to conduct a Phase 2b trial to test its APEX-52 psilocybin drug candidate to treat adults with post-traumatic stress disorder.
Archives for January 23, 2023
Upperton breaks ground on £15m manufacturing facility
A UK CDMO has started work on the construction of its development and GMP manufacturing headquarters in Nottingham, UK.